Avg closing price

Price range

20 Polen Capital Regeneron Pharmaceuticals, Inc. transactions

Avg closing price
Price range
New holding (+2.16 Thousand shares) Q3 2021

Avg closing price

$620.82

Price range

$574.03 - $680.96
Sold -2 Million shares Q1 2021

Avg closing price

$486.87

Price range

$446.73 - $548.20
Increased shares by 3.4% (+65.1 Thousand shares) Q4 2020

Avg closing price

$539.80

Price range

$478.30 - $607.98
Increased shares by 5.0% (+93.1 Thousand shares) Q3 2020

Avg closing price

$606.33

Price range

$544.75 - $658.21
Increased shares by 7.2% (+124 Thousand shares) Q2 2020

Avg closing price

$567.62

Price range

$493.32 - $643.92
Increased shares by 2.7% (+44.7 Thousand shares) Q1 2020

Avg closing price

$412.49

Price range

$336.18 - $494.43
Increased shares by 2.1% (+34.1 Thousand shares) Q4 2019

Avg closing price

$336.44

Price range

$274.13 - $376.51
Increased shares by 3.6% (+57.1 Thousand shares) Q3 2019

Avg closing price

$295.91

Price range

$273.46 - $318.39
Sold 1.1% shares (-17.4 Thousand shares) Q2 2019

Avg closing price

$332.92

Price range

$299.60 - $414.82
Increased shares by 7.9% (+117 Thousand shares) Q1 2019

Avg closing price

$411.79

Price range

$372.08 - $439.57
Sold 0.2% shares (-3.24 Thousand shares) Q4 2018

Avg closing price

$366.02

Price range

$335.82 - $403.04
Increased shares by 0.3% (+4.86 Thousand shares) Q3 2018

Avg closing price

$380.58

Price range

$351.14 - $408.51
Increased shares by 4.5% (+64.5 Thousand shares) Q2 2018

Avg closing price

$312.75

Price range

$284.60 - $344.99
Increased shares by 2.1% (+29.6 Thousand shares) Q1 2018

Avg closing price

$347.81

Price range

$315.82 - $393.78
Increased shares by 1.2% (+15.9 Thousand shares) Q4 2017

Avg closing price

$405.00

Price range

$358.63 - $469.95
Sold 13.4% shares (-213 Thousand shares) Q3 2017

Avg closing price

$475.84

Price range

$431.38 - $521.22
Increased shares by 7.3% (+108 Thousand shares) Q2 2017

Avg closing price

$437.61

Price range

$366.06 - $526.53
Increased shares by 10.2% (+137 Thousand shares) Q1 2017

Avg closing price

$370.66

Price range

$340.75 - $397.80
Increased shares by 65.2% (+529 Thousand shares) Q4 2016

Avg closing price

$380.27

Price range

$336.01 - $444.52
Increased shares by 3.0% (+23.4 Thousand shares) Q3 2016

Avg closing price

$401.14

Price range

$358.50 - $441.37

News about Regeneron Pharmaceuticals, Inc. and Polen Capital

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!